Defense Health Program Department of Defense Peer Reviewed Cancer Research Program Anticipated Funding Opportunities for Fiscal Year 2021 (FY21) - July 29, 2021 deadlines

How to Apply: 

Behavioral Health Science Award  - Letter of Intent due July 29, 2021

Independent investigator with a faculty-level appointment (or equivalent).

  • Letter of Intent is required. An invitation to submit a full application is not required.
  • Supports research that span the spectrum of behavioral health science including prevention, survivorship, quality of life, and psychosocial research related to cancer.
  • Must address at least one of the FY21 PRCRP Topic Areas.
  • Must address at least one of the FY21 PRCRP Military Health Focus Areas.
  • Preliminary data required.
  • Pilot clinical trials are allowed.
  • The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.

 

Career Development Award – Fellow Option – Letter of Intent due July 29, 2021

Principal Investigator (PI): Independent investigators at or above the level of Assistant Professor or Instructor (or equivalent) and within 7 years after completion of their terminal degree (excluding time spent in residency or on family medical leave) by the time of the application submission deadline.

Career Guide: Investigators at or above the level of Associate Professor (or equivalent); must have a proven publication and funding record in cancer research

  • Letter of Intent is required. An invitation to submit a full application is not required.
  • Supports independent, early-career investigators to conduct impactful research with the mentorship of an experienced cancer researcher.
  • Must address at least one of the FY21 PRCRP Topic Areas.
  • Must address at least one of the FY21 PRCRP Military Health Focus Areas.
  • Preliminary data are not required.
  • Clinical trials are not allowed.
  • The maximum allowable funding for the entire period of performance is $400,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.

 

Translational Team Science Award – Letter of Intent due July 29, 2021

At least two, and a maximum of three, PIs must partner in one overarching correlative or translational research study.

  • Letter of Intent is required.  An invitation to submit a full application is not required.
  • Emphasizes multi-PI, multidisciplinary collaborations.
  • Supports translational studies associated with an ongoing or completed clinical trial that can lead to a future clinical trial or clinical application in cancer research.
  • Not intended to support high throughput screenings, sequencing, etc.
  • Must address at least one of the FY21 PRCRP Topic Areas.
  • Must address at least one of the FY21 PRCRP Military Health Focus Areas.
  • Preliminary data are required.
  • Clinical Trials are allowed.
    • The maximum allowable funding for the entire period of performance is $2,500,000 for direct costs.
    • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
    • The maximum period of performance is 4 years.
    • At least one of the PIs is encouraged to be a military or US Department of Veterans Affairs investigator.
External Deadline: 
Thursday, July 29, 2021
Funding Source: 
External
Funding Level: 
Research